Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
9 drugs for “Chronic Lymphocytic Leukemia”
Approved 5
- AcalabrutinibASTRAZENECA PLCChronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma; Untreated Chronic Lymphocytic Leukemia
- SonrotoclaxBeOne Medicines Ltd.Chronic Lymphocytic Leukemia
- UblituximabTG THERAPEUTICS, INC.Chronic Lymphocytic Leukemia
- VenetoclaxAbbVie Inc.Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia (CLL)
- ZanubrutinibBeOne Medicines Ltd.Chronic Lymphocytic Leukemia
Phase 3 4
- BGB-16673BeOne Medicines Ltd.Chronic Lymphocytic Leukemia
- NemtabrutinibMerck & Co., Inc.Chronic Lymphocytic Leukemia
- NX-5948Nurix Therapeutics, Inc.Chronic Lymphocytic Leukemia
- TacabrutidegBeOne Medicines Ltd.Chronic Lymphocytic Leukemia
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.